China Universal Asset Management Co., Ltd. Pyxis Oncology, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,609 shares of PYXS stock, worth $19,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,609Holding current value
$19,670% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
99Shares Held
28.2MCall Options Held
539KPut Options Held
54.1K-
Deep Track Capital, LP Greenwich, CT4.18MShares$6.53 Million0.57% of portfolio
-
Laurion Capital Management LP New York, NY3.63MShares$5.66 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$4.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$3.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.91MShares$2.97 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $54.8M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...